Positive cross-talk between 17β-estradiol and TNFα in inflammatory and angiogenic pathways, and the ability of TNFα to modulate gene regulation by 17β-estradiol may explain, in part, why associations were strongest for premenopausal EA women and ER positive breast cancers [46]. The gene discussed is TNF; the disease is breast cancer.